CEBPA and Obesity: A recent obesity study reports that the fractionation products or extracts derived from Staphylococcus and Lactobacillus inhibit triglyceride accumulation through changes in C/EBP-α and PPAR-γ in 3T3-L1 adipocyte differentiation [44].